A stronger 7.2 mg dose of Wegovy wins FDA approval after a 54-day review, promising greater weight loss for eligible patients ...

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

A federal court blocks changes to the childhood immunization schedule by the recently appointed vaccine advisory committee; higher dose Wegovy injection gets green light; Cosentyx expanded to include ...

Just about 10 weeks after it was approved by the US Food and Drug Administration, the Wegovy pill is now estimated to be part of the daily regimen of about ...

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about ...

Semaglutide went off patent in India on March 20, immediately drawing in generic manufacturers with prices starting as low as ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

The FDA approved the new injectable Wegovy HD, or “higher dose,” which has about three times as much medication per shot as ...

A higher dose of Novo Nordisk’s GLP-1 injection Wegovy is coming to U.S. pharmacy shelves next month. The Danish drugmaker on Thursday announced the approval of a 7.2 mg dose ca ...

The FDA granted approval for the GLP-1 dosage in just 54 days. The Wegovy pill, rather than injections, was approved in December.

New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs may not be the same for every patient.

U.S. regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy—a 7.2-milligram dose of ...